AGTC News and Press, Applied Genetic Technologies Corporation From 03/06/19

Applied Genetic Technologies ( AGTC ) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases, explains Bill Mathews , small cap expert and editor of ...

Applied Genetic Technologies Corporation (AGTC) Q2 2019 Earnings Conference Call February 7, 2019 8:00 AM ET Company Participants Sue Washer - President and Chief Executive Officer Matthew Feinsod - Chief Medical Officer William Sullivan - Chief Financial Officer Conference Ca...

Applied Genetic ( AGTC ) Q2 results : Revenues: $5.9M (+20.4%). More news on: Applied Genetic Technologies Corporation, Healthcare stocks news, Earnings news and commentary, , Read more ...

Applied Genetic (NASDAQ: AGTC ): Q2 GAAP EPS of -$0.23 beats by $0.45 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...